STIM Nov 2024 5.000 call
| Previous Close | 0.2500 |
| Open | 0.2000 |
| Bid | 0.0500 |
| Ask | 0.2500 |
| Strike | 5.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 0.1000 - 0.2000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 8 |
GlobeNewswireNeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024MALVERN, Pa., June 13, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today their participation at the 12th Annual Meeting of the Clinical TMS Society (CTMSS) in London, England from June 13
GuruFocus.comDirector Robert Cascella Acquires 50,000 Shares of Neuronetics Inc (STIM)
On June 6, 2024, Robert Cascella, a Director at Neuronetics Inc (NASDAQ:STIM), purchased 50,000 shares of the company, as reported in a recent SEC Filing.
- GlobeNewswire
Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the William Blair 44th Annual Growth Stock Conference on Thursday, June 6, 2024. The Company is scheduled to present at 10:00am Central Time the same day via webcast. A live audio webcast of
